[Anti-angiogenic therapy for breast cancer--problems and future directions].
Department of Breast Oncology, Aichi Cancer Center Hospital.
Masataka
M
Sawaki
Hiroji
H
Iwata
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000068258:Bevacizumab; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans
D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab